Meeting
2012 ASCO Annual Meeting
Racial differences in outcomes of triple-negative breast cancer.
Authors
Jose Pacheco
Washington University, St. Louis, MO
Jose Pacheco , Feng Gao , Caroline Bumb , Matthew J. Ellis , Cynthia X. Ma
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy
Track
Breast Cancer
Sub Track
Triple-Negative Breast Cancer
Citation
J Clin Oncol 30, 2012 (suppl; abstr 1048)
DOI
10.1200/jco.2012.30.15_suppl.1048
Abstract #
1048
Poster Bd #
20G
Abstract Disclosures
Similar Posters
Poster
2012 ASCO Annual Meeting
Topoisomerase II alpha gene status, HER2, and microtubule-associated protein tau as predictors of pathologic complete response after neoadjuvant chemotherapy.
First Author: Agust Barnadas
Poster
2023 ASCO Annual Meeting
Artificial intelligence (AI) –based machine learning models (ML) for predicting pathological complete response (pCR) in patients with hormone receptor (HoR) –positive/HER2-negative early breast cancer (EBC) undergoing neoadjuvant chemotherapy (NCT): A retrospective cohort study.
First Author: Luca Mastrantoni
Poster
2022 ASCO Annual Meeting
Does race influence long-term outcomes after neoadjuvant chemotherapy in breast cancer: A National Cancer Database analysis.
First Author: Arya Mariam Roy
Poster
2019 ASCO Annual Meeting
Race and response to neoadjuvant chemotherapy according to MammaPrint risk.
First Author: Raquel Nunes